Heartflow Competitors
| HTFL Stock | 28.24 0.15 0.53% |
Heartflow Common vs Travere Therapeutics Correlation
Very good diversification
The correlation between Heartflow Common Stock and TVTX is -0.42 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Heartflow Common Stock and TVTX in the same portfolio, assuming nothing else is changed.
Moving against Heartflow Stock
Return On Equity is expected to rise to 0.13 this year, although the value of Return On Tangible Assets will most likely fall to (1.05). At this time, Heartflow Common's Total Assets are quite stable compared to the past year. Total Current Assets is expected to rise to about 92.3 M this year, although the value of Non Current Assets Total will most likely fall to about 29.2 M.Heartflow Common Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Heartflow Common and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Heartflow and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Heartflow Common Stock does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Heartflow Stock performing well and Heartflow Common Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Heartflow Common's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| TARS | 1.57 | (0.02) | (0.02) | 0.00 | 2.14 | 3.78 | 12.48 | |||
| PRVA | 1.43 | (0.16) | 0.00 | (0.45) | 0.00 | 2.90 | 10.42 | |||
| LIVN | 1.58 | 0.30 | 0.17 | 0.40 | 1.46 | 4.27 | 12.50 | |||
| ATEC | 2.37 | (0.16) | 0.00 | (0.17) | 0.00 | 3.57 | 38.63 | |||
| IRON | 1.99 | (0.07) | 0.00 | 1.45 | 0.00 | 4.33 | 14.87 | |||
| LEGN | 2.29 | (0.94) | 0.00 | 6.32 | 0.00 | 3.83 | 19.65 | |||
| SGRY | 2.08 | (0.65) | 0.00 | (3.22) | 0.00 | 3.53 | 26.78 | |||
| ZLAB | 1.88 | (0.65) | 0.00 | (2.30) | 0.00 | 4.56 | 10.32 | |||
| PRGO | 1.97 | (0.54) | 0.00 | (0.92) | 0.00 | 3.42 | 25.71 | |||
| TVTX | 2.83 | 0.16 | 0.05 | 0.15 | 3.49 | 6.31 | 33.22 |
Cross Equities Net Income Analysis
Compare Heartflow Common Stock and related stocks such as Tarsus Pharmaceuticals, Privia Health Group, and LivaNova PLC Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TARS | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (4.7 M) | (26.8 M) | (13.8 M) | (62.1 M) | (135.9 M) | (115.6 M) | (104 M) | (98.8 M) |
| PRVA | (3 M) | (3 M) | (3 M) | (3 M) | (3 M) | (3 M) | (3 M) | (3 M) | (3 M) | 8.2 M | 31.2 M | (188.2 M) | (8.6 M) | 23.1 M | 14.4 M | 16.5 M | 17.4 M |
| LIVN | (5.1 M) | 36.1 M | 46.4 M | 54.9 M | 54.9 M | 57.8 M | (62.8 M) | (25.1 M) | (189.4 M) | (157.6 M) | (348.8 M) | (135.8 M) | (86.2 M) | 17.5 M | 63.2 M | 56.9 M | 59.8 M |
| ATEC | 91.9 K | (22.2 M) | (15.5 M) | (82.2 M) | (12.9 M) | (178.7 M) | (30.3 M) | (2.3 M) | (29 M) | (57 M) | (79 M) | (143 M) | (151.3 M) | (186.6 M) | (162.1 M) | (145.9 M) | (138.6 M) |
| IRON | (40.8 M) | (40.8 M) | (40.8 M) | (40.8 M) | (40.8 M) | (40.8 M) | (40.8 M) | (40.8 M) | (40.8 M) | (40.8 M) | (40.8 M) | (36 M) | (46.1 M) | (76.4 M) | (109.4 M) | (98.4 M) | (103.3 M) |
| LEGN | 9.4 M | 9.4 M | 9.4 M | 9.4 M | 9.4 M | 9.4 M | 9.4 M | 9.4 M | (2.8 M) | (101.6 M) | (266.4 M) | (403.6 M) | (446.3 M) | (518.3 M) | (177 M) | (159.3 M) | (167.3 M) |
| SGRY | 1.9 M | 1.9 M | 1.9 M | (9.1 M) | (65.9 M) | 1.4 M | 9.5 M | (53 M) | (205.7 M) | (74.8 M) | (116.1 M) | (70.9 M) | (54.6 M) | (11.9 M) | (168.1 M) | (151.3 M) | (143.7 M) |
| ZLAB | (18 M) | (18 M) | (18 M) | (18 M) | (18 M) | (18 M) | (37.5 M) | (50.4 M) | (139.1 M) | (183.4 M) | (268.9 M) | (704.5 M) | (443.3 M) | (334.6 M) | (257.1 M) | (231.4 M) | (243 M) |
| PRGO | 28.6 M | 401.6 M | 441.9 M | 205.3 M | 205.3 M | 127.9 M | (4 B) | 119.6 M | 131 M | 146.1 M | (162.6 M) | (68.9 M) | (140.6 M) | (12.7 M) | (171.8 M) | (154.6 M) | (146.9 M) |
| TVTX | (18.3 K) | (14.8 K) | (30.3 M) | (33.8 M) | (110.9 M) | 117.2 M | (47.9 M) | (59.7 M) | (102.7 M) | (146.4 M) | (169.4 M) | (180.1 M) | (278.5 M) | (111.4 M) | (321.5 M) | (289.4 M) | (274.9 M) |
Heartflow Common Stock and related stocks such as Tarsus Pharmaceuticals, Privia Health Group, and LivaNova PLC Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Heartflow Common Stock financial statement analysis. It represents the amount of money remaining after all of Heartflow Common Stock operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Heartflow Common Competitive Analysis
The better you understand Heartflow Common competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Heartflow Common's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Heartflow Common's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Heartflow Common Competition Performance Charts
Five steps to successful analysis of Heartflow Common Competition
Heartflow Common's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Heartflow Common Stock in relation to its competition. Heartflow Common's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Heartflow Common in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Heartflow Common's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Heartflow Common Stock, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Heartflow Common position
In addition to having Heartflow Common in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Money Funds Thematic Idea Now
Money Funds
Funds or Etfs that invest most if their asset in companies from financial sector such as commercial banks, insurance companies, investment funds, and real estate. The Money Funds theme has 34 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Money Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Heartflow Common Correlation with its peers. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Heartflow Common. Market participants price Heartflow higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Heartflow Common assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate Heartflow Common Stock using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Heartflow Common's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Heartflow Common's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Heartflow Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if Heartflow Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Heartflow Common's market price signifies the transaction level at which participants voluntarily complete trades.